Cancer cure (CURE)

While there is no single "cure" for cancer from fusion energy, the technology behind nuclear fusion is driving breakthroughs in treating cancer through more precise radiation and the production of rare life-saving isotopes.
Medical Isotopes via Fusion
The most immediate medical application of fusion is the production of radioactive isotopes used in Targeted Alpha Therapy (TAT). Companies like Shine Technologies and Astral Systems are building compact fusion reactors to create medical isotopes like Lutetium-177 and Molybdenum-99.
New Scientist
New Scientist
+3
Actinium-225: Known as the "rarest drug in the world," this isotope emits alpha radiation that can destroy cancer cells with pinpoint accuracy without the usual side effects like hair loss.
Domestic Supply: Fusion-based production allows these isotopes to be made more sustainably and closer to hospitals, solving the problem of their extremely short shelf lives (some decay in just hours or days).
United Kingdom National Nuclear Laboratory
United Kingdom National Nuclear Laboratory
+3
Precision Beam Technology
Fusion research requires the development of high-powered particle beams, which are now being adapted for cancer treatment:
Boron Neutron Capture Therapy (BNCT): Companies such as TAE Life Sciences (a spinoff of a fusion energy firm) use compact accelerators—originally designed for fusion reactors—to fire neutron beams at boron-injected tumors. This causes a localized explosion that kills the cancer cell from the inside while sparing healthy tissue.